Quantcast

Latest Institute of Cancer Research Stories

2008-10-07 09:00:56

Cancer drug developer Antisoma, The Institute of Cancer Research and Cancer Research Technology have announced a collaboration and licensing agreement under which Antisoma has acquired rights to develop and commercialize novel anticancer compounds called protein phosphatase magnesium-dependent 1 d inhibitors. Work carried out at the Breakthrough Breast Cancer Research Centre and at the Cancer Research UK Centre for Cancer Therapeutics, both of which are at The Institute of Cancer Research...

2008-10-07 03:00:23

Cancer drug developer Antisoma (LSE: ASM; USOTC: ATSMY), The Institute of Cancer Research (The Institute) and Cancer Research Technology (CRT) today announced a collaboration and licensing agreement under which Antisoma has acquired rights to develop and commercialise novel anti-cancer compounds called PPM1D (protein phosphatase magnesium-dependent 1 d) inhibitors. Work carried out at the Breakthrough Breast Cancer Research Centre and at the Cancer Research UK Centre for Cancer...

2008-10-05 00:00:06

By Nina Lakhani As money floods in for breast cancer and leukaemia research, 80 per cent of people with lung tumours are dying within a year of diagnosis Patients suffering from "unfashionable" cancers are being neglected by scientists in spite of record spending on cancer research, according to a new report by the National Cancer Research Institute (NCRI). Some of the deadliest cancers, such as those affecting the lung and pancreas, get the least amount of public money, while five...

2008-07-28 18:00:17

SCIENTISTS are hailing a new drug to treat aggressive prostate cancer as potentially the most significant advance in the field for 70 years. Abiraterone could treat up to 80% of patients with a deadly form of the disease resistant to currently available chemotherapy, they said. The drug works by blocking the hormones which fuel the cancer. The Institute of Cancer Research hopes a simple pill form will be available in two to three years. An advanced clinical trial involving 1,200...

2008-07-24 00:00:18

By Phil Skelton Health reporter Prostate cancer patients in Gloucestershire have welcomed news of a new drug to treat an aggressive form of the disease. Abiraterone has been developed to fight prostate cancer, which kills 9,000 men in England and Wales every year, according to the NHS. Preliminary trials have shown that the drug can reverse even the most aggressive cancers in up to 80 per cent of cases. It works by blocking the hormones which fuel the cancer. The Institute of Cancer...

2008-07-22 21:00:17

The Phase 1 clinical trial of the drug abiraterone revealed significant tumor shrinkage in men with advanced prostate cancer, researchers in Britain said. The trial also found dramatic falls in the prostate specific antigen levels in the majority of advanced prostate cancer patients who received the drug. The clinical trial was undertaken by London-based The Institute of Cancer Research and The Royal Marsden Hospital. Lead researcher Dr. Johann de Bono said the the new drug...

2008-07-22 18:00:21

MEN who expect to die from prostate cancer have been offered new hope by a drug which could represent the biggest step forward in treating the disease in 60 years. A preliminary trial has shown that abiraterone can reverse even the most aggressive, resistant and deadly cancers. Doctors believe it could potentially prolong the lives of up to 10,000 British men each year. Between 70% and 80% of ill men treated with the drug have shown improvements. In between 20% and 30% of cases...

2008-07-22 06:00:17

By Lyndsay Moss THE last decade has seen major leaps forward in cancer treatment in the search for the latest "wonder drug". Developments such as the creation of drugs which target particular types of cancer have brought new hope to patients. These include treatments such as Herceptin for breast cancer, which works when cancer cells have a large amount of a protein called HER2. New drugs are also being developed that block hormones driving many cancers, such as prostate, testicular...

2008-07-22 06:00:17

By Lyndsay Moss THOUSANDS of men with prostate cancer could be helped by an "exciting" new drug which potentially represents the biggest step forward in treating the disease for 60 years, researchers revealed yesterday. The drug, abiraterone, could help prolong the lives of up to 10,000 men in the UK each year who suffer the most aggressive - and almost always fatal - form of the disease. The news came after a study found the drug led to tumours shrinking in up to 80 per cent of...

2008-07-22 03:00:18

A WONDER pill blocks the advance of prostate cancer with hardly any side effects, it is claimed. Experts believe Abiraterone could treat eight out of 10 aggressive tumours that have resisted all other treatments. Trials have shown the drug, taken as daily pills, cuts cancer levels by 30 per cent in 80 per cent of men in three months. Patients in severe pain say they have been given a new lease of life by the drug. That has led to a "stampede" of men wanting to take part in clinical...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.